Status:
UNKNOWN
Quadratus Lumborum Block Versus Thoracic Paravertebral Block
Lead Sponsor:
National Cancer Institute, Egypt
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Postoperative Analgesia
Eligibility:
FEMALE
20-70 years
Phase:
NA
Brief Summary
This study is to assess and compare the analgesic efficacy and safety of quadratus lumbotum block and paravertebral block in gynacological cancer patients.
Detailed Description
All patients will be medically checked in the preoperative assessment clinic {history, physical examination, investigations (e.g. complete blood picture, coagulation profile , liver \& kidney function...
Eligibility Criteria
Inclusion
- 1\. Inclusion criteria
- ASA I-III.
- Age ≥ 20 \& ≤ 70
- Body mass index (BMI): Less than forty and more than twenty.
- Patients undergoing major gynacological cancer surgeries.
- 2\. Exclusion criteria
- Patient refusal.
- History of sensitivity to local anesthetic (amide group).
- History of psychological disorders.
- Coagulopathies: hereditary (e.g. hemophilia, fibrinogen abnormalities\& deficiency of factor II) - acquired (e.g. liver disease, vitamin K deficiency \& therapeutic anticoagulants drugs).
- Localized infection.
- Morbid obese BMI\>40.
- Incooperative patients.
- Patients on chronic pain therapy.
Exclusion
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04827043
Start Date
April 1 2021
End Date
September 30 2021
Last Update
April 1 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.